Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin Inactivated Poliovirus Vaccine (Vero cell) sequential 1+2 schedule in infants
CTR20180526Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin strain inactivated poliovirus vaccine in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started May 2018; status: completed.
02
Drugs
Sabin strain inactivated poliovirus vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20180526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180526.